Travel Medicine and Infectious Disease最新文献

{"title":"Primaquine-induced hemolysis in a Colombian patient with glucose-6-phosphate dehydrogenase deficiency","authors":"Daniel Celis-Giraldo, María Alejandra Fajardo, Diana Camila Romo Arteaga, Álvaro A. Faccini-Martínez","doi":"10.1016/j.tmaid.2024.102748","DOIUrl":"10.1016/j.tmaid.2024.102748","url":null,"abstract":"","PeriodicalId":23312,"journal":{"name":"Travel Medicine and Infectious Disease","volume":"61 ","pages":"Article 102748"},"PeriodicalIF":6.3,"publicationDate":"2024-07-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S1477893924000644/pdfft?md5=4e3c5f2ceb640fbbd38d59d2c5ab4a44&pid=1-s2.0-S1477893924000644-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141861042","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Impact of species hybridization on the clinical management of schistosomiasis: A prospective study","authors":"Joaquín Salas-Coronas ,&nbsp;M. Dolores Bargues ,&nbsp;Pedro Fernández-Soto ,&nbsp;Manuel J. Soriano-Pérez ,&nbsp;Patricio Artigas ,&nbsp;José Vázquez-Villegas ,&nbsp;Antonio Villarejo-Ordoñez ,&nbsp;José C. Sánchez-Sánchez ,&nbsp;María I. Cabeza-Barrera ,&nbsp;Begoña Febrer-Sendra ,&nbsp;Alejandra De Elías-Escribano ,&nbsp;Beatriz Crego-Vicente ,&nbsp;María C. Fantozzi ,&nbsp;Juan García-Bernalt Diego ,&nbsp;Nerea Castillo-Fernández ,&nbsp;Jaime Borrego-Jiménez ,&nbsp;Antonio Muro ,&nbsp;María P. Luzón-García","doi":"10.1016/j.tmaid.2024.102744","DOIUrl":"10.1016/j.tmaid.2024.102744","url":null,"abstract":"<div><h3>Background</h3><p>Species hybridization represents a real concern in terms of parasite transmission, epidemiology and morbidity of schistosomiasis. It is greatly important to better understand the impact of species hybridization for the clinical management.</p></div><div><h3>Methods</h3><p>A prospective observational study was carried out in sub-Saharan migrants who were diagnosed with confirmed genitourinary schistosomiasis. A tailored protocol was applied, including <em>Schistosoma</em> serology, a specific urine LAMP tests for schistosomiasis and an ultrasound examination before treatment with praziquantel. A scheduled follow-up was performed at 3, 6 and 12 months to monitor treatment response, comparing patients carriers of <em>Schistosoma</em> hybrids with carriers of only genetically pure forms.</p></div><div><h3>Results</h3><p>A total of 31 male patients from West Africa were included in the study with a mean age of 26.5 years. Twelve (38.7 %) of the patients were carriers of <em>Schistosoma</em> hybrids. As compared with patients infected with <em>S. haematobium</em> alone, hybrid carriers had lower haemoglobin levels (13.8 g/dL [SD 1.8] vs 14.8 g/dL [SD 1.4], p = 0.04), a greater frequency of hematuria (100 % <em>vs</em> 52.6 %, p = 0.005), a higher ultrasound score (2.64, SD 2.20 vs 0.89, SD 0.99; p = 0.02). However, the presence of hybrids did not result in differences in clinical and analytical responses after treatment.</p></div><div><h3>Conclusions</h3><p>The presence of <em>Schistosoma</em> hybrids seems to cause increased morbidity in infected individuals. However, it does not appear to result in differences in diagnostic tests or in clinical and analytical responses after treatment.</p></div>","PeriodicalId":23312,"journal":{"name":"Travel Medicine and Infectious Disease","volume":"61 ","pages":"Article 102744"},"PeriodicalIF":6.3,"publicationDate":"2024-07-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S1477893924000607/pdfft?md5=4ec115016baa650e8c87d491a5132279&pid=1-s2.0-S1477893924000607-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141761165","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Necrotizing mpox with persistent microbiological positivity despite the use of tecovirimat: A case report","authors":"Pierluigi Francesco Salvo,&nbsp;Gianmaria Baldin,&nbsp;Elena Visconti,&nbsp;Simona Di Giambenedetto","doi":"10.1016/j.tmaid.2024.102746","DOIUrl":"10.1016/j.tmaid.2024.102746","url":null,"abstract":"","PeriodicalId":23312,"journal":{"name":"Travel Medicine and Infectious Disease","volume":"61 ","pages":"Article 102746"},"PeriodicalIF":6.3,"publicationDate":"2024-07-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S1477893924000620/pdfft?md5=08d5d947215ca3b3272a25ae86577697&pid=1-s2.0-S1477893924000620-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141761166","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Association between positive serology for COVID-19 and chagas cardiomyopathy progression: The SaMi-Trop project","authors":"Ariela Mota Ferreira ,&nbsp;Léa Campos Oliveira-da Silva ,&nbsp;Clareci Silva Cardoso ,&nbsp;Cláudia Di Lorenzo Oliveira ,&nbsp;Bruno Oliveira de Figueiredo Brito ,&nbsp;Ana Luiza Bierrenbach ,&nbsp;Ana Clara de Jesus Santos ,&nbsp;Dardiane Santos Cruz ,&nbsp;Sâmara Fernandes Leite ,&nbsp;Andréia Brito Jesus ,&nbsp;Renata Fiúza Damasceno ,&nbsp;Maria Carmo Pereira Nunes ,&nbsp;Israel Molina ,&nbsp;Desirée Sant’ Anna Haikal ,&nbsp;Ester Cerdeira Sabino ,&nbsp;Antonio Luiz Pinho Ribeiro","doi":"10.1016/j.tmaid.2024.102745","DOIUrl":"10.1016/j.tmaid.2024.102745","url":null,"abstract":"<div><h3>Background</h3><p>Chagas Disease (CD) can cause Chagas cardiomyopathy. The new coronavirus disease (COVID-19) also affects the cardiovascular system and may worsen Chagas cardiomyopathy. However, the cardiac evolution of patients with CD infected by COVID-19 is not known. Thus, the objective of this study is to assess, within one year, whether there was cardiac progression after COVID-19 in CD.</p></div><div><h3>Methods</h3><p>Longitudinal study with CD patients. The outcome was cardiac progression, defined as the appearance of new major changes in the current ECG compared to the previous ECG considered from the comparison of electrocardiograms (ECGs) performed with an interval of one year. Positive Anti-SARS-CoV2 Serology was the independent variable of interest. For each analysis, a final multiple model was constructed, adjusted for sociodemographic, clinical, and pandemic-related characteristics.</p></div><div><h3>Results</h3><p>Of the 404 individuals included, 22.8 % had positive serology for COVID-19 and 10.9 % had cardiac progression. In the final model, positive serology for COVID-19 was the only factor associated with cardiac progression in the group as a whole (OR = 2.65; 95 % CI = 1.27–5.53) and for new-onset cardiomyopathy in the group with normal previous ECG (OR = 3.50; 95 % CI = 1.21–10.13).</p></div><div><h3>Conclusion</h3><p>Our study shows an association between COVID-19 and progression of Chagas cardiomyopathy, evaluated by repeated ECGs, suggesting that COVID-19 accelerated the natural history of CD.</p></div>","PeriodicalId":23312,"journal":{"name":"Travel Medicine and Infectious Disease","volume":"61 ","pages":"Article 102745"},"PeriodicalIF":6.3,"publicationDate":"2024-07-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S1477893924000619/pdfft?md5=74b22fe89142b3ac09a91e3deff0995b&pid=1-s2.0-S1477893924000619-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141761163","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Incidence and clinical significance of non-tuberculous mycobacteria among migrants in Denmark: A nationwide register-based cohort study from 1991 through 2021","authors":"","doi":"10.1016/j.tmaid.2024.102736","DOIUrl":"10.1016/j.tmaid.2024.102736","url":null,"abstract":"<div><h3>Background</h3><p>There is limited knowledge about non-tuberculous mycobacteria (NTM) infections in migrants. We aimed to assess the incidence and clinical significance of NTM among migrants in Denmark.</p></div><div><h3>Method</h3><p>Nationwide register-based cohort study of migrants with a positive NTM culture in Denmark from 1991 through 2021, stratified by patient demographics, disease localisation, species, and clinical significance.</p></div><div><h3>Results</h3><p>433 migrants had a positive NTM culture, resulting in an overall incidence rate (IR) of 3.7 (95%CI 3.3–4.0) per 100,000 migrants. Overall NTM IRs for definite disease were 1.0 (95%CI 0.9–1.2), possible disease 1.0 (95%CI 0.8–1.2), and isolation 1.7 (95%CI 1.4–1.9) per 100,000 migrants. Migrants had considerably higher age- and sex-adjusted NTM IRs of positive cultures (incidence rate ratio [IRR] = 2.1, 95%CI 1.9–2.3, p &lt; 0.001), possible disease (IRR = 2.4, 95%CI 2.0–3.0, p &lt; 0.001), and isolation (IRR = 4.6, 95%CI 3.9–5.4, p &lt; 0.001) compared to Danish-born, but not of definite disease (IRR = 1.1, 95%CI 0.9–1.3, p = 0.562). IRs of migrants with positive NTM cultures did not increase over time (−0.8 %/year, p = 0.133).</p></div><div><h3>Conclusions</h3><p>Migrants have a higher, but stable, burden of NTM compared with Danish-born. The higher rates likely reflect that more specimens are examined for <em>Mycobacterium tuberculosis</em>. Microbiologically classified definite NTM disease is not substantially more common among migrants.</p></div>","PeriodicalId":23312,"journal":{"name":"Travel Medicine and Infectious Disease","volume":"61 ","pages":"Article 102736"},"PeriodicalIF":6.3,"publicationDate":"2024-07-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S1477893924000528/pdfft?md5=83362da17dd22b80c1c5746b94e5919f&pid=1-s2.0-S1477893924000528-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141601879","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Mosquito-borne Murray Valley encephalitis: Re-emergence in Western Australia","authors":"","doi":"10.1016/j.tmaid.2024.102734","DOIUrl":"10.1016/j.tmaid.2024.102734","url":null,"abstract":"","PeriodicalId":23312,"journal":{"name":"Travel Medicine and Infectious Disease","volume":"60 ","pages":"Article 102734"},"PeriodicalIF":6.3,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S1477893924000504/pdfft?md5=ef8e8c4135e47d808684c3e048b49b4a&pid=1-s2.0-S1477893924000504-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141601880","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Zika and Chikungunya in Europe 2100 – A GIS based model for risk estimation","authors":"J. Kronen ,&nbsp;M. Leuchner ,&nbsp;T. Küpper","doi":"10.1016/j.tmaid.2024.102737","DOIUrl":"10.1016/j.tmaid.2024.102737","url":null,"abstract":"<div><h3>Background</h3><p>The spread of vector-borne infectious diseases is determined, among other things, by temperature. Thus, climate change will have an influence on their global distribution. In the future, Europe will approach the temperature optimum for the transmission of ZIKV and CHIKV. Climate scenarios and climate models can be used to depict future climatic changes and to draw conclusions about future risk areas for vector-borne infectious diseases.</p></div><div><h3>Methods</h3><p>Based on the RCP 4.5 and RCP 8.5 climate scenarios, a geospatial analysis was carried out for the future temperature suitability of ZIKV and CHIKV in Europe. The results were presented in maps and the percentage of the affected areas calculated.</p></div><div><h3>Results</h3><p>Due to rising temperatures, the risk areas for transmission of ZIKV and CHIKV spread in both RCP scenarios. For CHIKV transmission, Spain, Portugal, the Mediterranean coast and areas near the Black Sea are mainly affected. Due to high temperatures, large areas throughout Europe are at risk for ZIKV and CHIKV transmission.</p></div><div><h3>Conclusion</h3><p>Temperature is only one of many factors influencing the spread of vector-borne infectious diseases. Nevertheless, the representation of risk areas on the basis of climate scenarios allows an assessment of future risk development. Monitoring and adaptation strategies are indispensable for coping with and containing possible future autochthonous transmissions and epidemics in Europe.</p></div>","PeriodicalId":23312,"journal":{"name":"Travel Medicine and Infectious Disease","volume":"60 ","pages":"Article 102737"},"PeriodicalIF":6.3,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S147789392400053X/pdfft?md5=884527ce36de6a0fcea841a593afdfe9&pid=1-s2.0-S147789392400053X-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141601882","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Unexpected discovery of Trypanosoma brucei gambiense on CSF in a western country: About a case","authors":"Lou-Ann Francois,&nbsp;Laurent Bret,&nbsp;Jonathan Wong So,&nbsp;Camelia Gubavu,&nbsp;Feriel Touafek,&nbsp;Morgane Vinsonneau,&nbsp;Khaoula Kochbati,&nbsp;Véronique Avettand-Fenoel,&nbsp;Clemence Guillaume,&nbsp;Etienne Carbonnelle,&nbsp;Jérôme Guinard,&nbsp;Gilbert Mchantaf","doi":"10.1016/j.tmaid.2024.102741","DOIUrl":"10.1016/j.tmaid.2024.102741","url":null,"abstract":"","PeriodicalId":23312,"journal":{"name":"Travel Medicine and Infectious Disease","volume":"60 ","pages":"Article 102741"},"PeriodicalIF":6.3,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S1477893924000577/pdfft?md5=2cfcc390c73f8a1d45400581db307056&pid=1-s2.0-S1477893924000577-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141617141","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Not all severe malaria cases are severe: Is it time to redefine severity criteria for malaria in non-endemic regions?","authors":"Leire Balerdi-Sarasola ,&nbsp;Jose Muñoz ,&nbsp;Pedro Fleitas ,&nbsp;Natalia Rodriguez-Valero ,&nbsp;Alex Almuedo-Riera ,&nbsp;Alba Antequera ,&nbsp;Carme Subirà ,&nbsp;Ignacio Grafia-Perez ,&nbsp;Maria Ortiz-Fernández ,&nbsp;Tessa de Alba ,&nbsp;Miriam J. Álvarez-Martínez ,&nbsp;M Eugenia Valls ,&nbsp;Claudio Parolo ,&nbsp;Pedro Castro ,&nbsp;Daniel Camprubí-Ferrer","doi":"10.1016/j.tmaid.2024.102740","DOIUrl":"10.1016/j.tmaid.2024.102740","url":null,"abstract":"<div><h3>Background</h3><p>The current definition of severe malaria in non-endemic areas follows WHO criteria, which mainly target children in malaria-endemic areas, potentially misclassifying cases in non-endemic regions. We assessed the performance of a modified severe malaria classification criteria within our patient cohort.</p></div><div><h3>Methods</h3><p>A cohort study of patients managed for malaria in a non-endemic setting (2005–2023) was analyzed. We classified patients into severe malaria (SM) using WHO 2013 criteria except for hyperparasitemia, where 2 % threshold was applied. Patients with SM were distinguished as very severe malaria (VSM) when presenting at least one of the following conditions: parasitemia &gt;10 %, pulmonary edema, impaired consciousness, seizures, renal failure, metabolic acidosis or hyperlactatemia, shock or hypoglycemia. In patients with SM and no criteria for VSM, less severe malaria (LSM) was defined by: 2–10 % parasitemia, hyperbilirubinemia, prostration, anemia or minor bleeding. The primary composite outcome was death or the need for a life-saving intervention, as analyzed in the three comparative groups. Secondary outcome was the prevalence of co-infections.</p></div><div><h3>Results</h3><p>Among 506 patients with malaria, 176 (34.8 %) presented with SM. A total of 37 (7.3 %) patients developed a life-threatening condition, namely death (n = 4) and/or the need for life-saving interventions (n = 34). All fatalities and 33 out of the 34 life-saving interventions occurred in the VSM group. Patients in LSM group did not develop any life-threatening conditions. As to co-infections, 28 (5.5 %) patients had a community-acquired co-infection, with no differences between groups (p = 0.763).</p></div><div><h3>Conclusions</h3><p>Severity criteria definitions would benefit from a review when assessing patients with malaria in non-endemic areas. Within the spectrum of SM, patients reclassified as LSM have a low risk of developing a life-threatening condition and present low co-infection incidence and could benefit from management out of intensive care units and a restrictive use of empirical antibiotics.</p></div>","PeriodicalId":23312,"journal":{"name":"Travel Medicine and Infectious Disease","volume":"60 ","pages":"Article 102740"},"PeriodicalIF":6.3,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S1477893924000565/pdfft?md5=d45330cc47982cd68d0c4b9dc1722df4&pid=1-s2.0-S1477893924000565-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141604201","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Communicable diseases in Ukraine during the period of 2018–2023: Impact of the COVID-19 pandemic and war","authors":"Pavlo Petakh ,&nbsp;Viktoriia Tymchyk ,&nbsp;Oleksandr Kamyshnyi","doi":"10.1016/j.tmaid.2024.102733","DOIUrl":"10.1016/j.tmaid.2024.102733","url":null,"abstract":"<div><h3>Background</h3><p>By examining 2018–2023 data, this study explored the intricate impact of the Russian invasion, ongoing COVID-19 pandemic, and environmental disruptions on communicable diseases in Ukraine. This conflict exacerbates challenges in disease surveillance and healthcare, compounding stress among the population.</p></div><div><h3>Methods</h3><p>Leveraging the Centers for Disease Prevention Control's surveillance system, the study employs active and passive surveillance, utilizing medical records and laboratory reports. Notification rates gauge the incidence of communicable diseases, offering insights into trends during the study period.</p></div><div><h3>Results</h3><p>While salmonellosis, shigellosis, and rotavirus incidence are decreasing overall, there is a surge in viral hepatitis A, chronic hepatitis B, and C. This conflict hampers hepatitis C management, as evidenced by decreased numbers of treatment centers and patient enrollment. The prevalence of cough cases will increase in 2023, emphasizing the importance of sustained vaccination. The incidence of tuberculosis will increase in 2023 despite a general decrease.</p></div><div><h3>Conclusion</h3><p>This study underscores the urgent need for sustained efforts and adequate resources, infrastructure, and international support to mitigate public health challenges in conflict-ridden Ukraine. Prioritizing vaccination programmes and enhancing healthcare accessibility in affected regions are crucial.</p></div>","PeriodicalId":23312,"journal":{"name":"Travel Medicine and Infectious Disease","volume":"60 ","pages":"Article 102733"},"PeriodicalIF":6.3,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S1477893924000498/pdfft?md5=2664293ccbfb3a04d1608790e74987f3&pid=1-s2.0-S1477893924000498-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141470920","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}